Read more about EU regulator rejects Alzheimer's drug lecanemab
Read more about EU regulator rejects Alzheimer's drug lecanemab
EU regulator rejects Alzheimer's drug lecanemab

The European Medicines Agency (EMA) has rejected a licence for an Alzheimer’s treatment which slows cognitive decline.
Want to read more?

You can publish here, too - it's easy and free.